Plaquenil is used to treat or prevent malaria, a disease caused by parasites that enter the body through the bite of a mosquito. Malaria is common in areas such as Africa, South America, and Southern Asia. Walgreens hydroxychloroquine How to take chloroquine for malaria prophylaxis Hydroxychloroquine dose for malaria Neutropenia in Felty’s syndrome successfully treated with hydroxychloroquine. hydroxychloroquine. for the treatment of severe neutropenia due to Felty's syndrome FS or systemic lupus. Hydroxychloroquine oral tablet is available as a brand-name drug and a generic drug. Brand name Plaquenil. Hydroxychloroquine comes only as a tablet you take by mouth. Hydroxychloroquine is used to treat malaria, lupus erythematosus, and rheumatoid arthritis. Thrombocytopenia is a common problem occurring in patients and drug-induced thrombocytopenia is a significant cause of present an unusual case of thrombocytopenia that was considered to be associated with the use of hydroxychloroquine. Plaquenil is also an antirheumatic medicine and is used to treat symptoms of rheumatoid arthritis and discoid or systemic lupus erythematosus. This medicine is not effective against all strains of malaria. Neutropenia hydroxychloroquine Rheumatoid Arthritis Treatment Options Johns, Hydroxychloroquine Side Effects, Dosage, Uses, and More Chloroquine avloclorSulfasalazine and hydroxychloroquine rheumatoid arthritisGuidelines for plaquenil screening Plaquenil hydroxychloroquine is a medication most known for its original purpose of treating or preventing malaria, a disease caused by parasites that enter the body through the bite of a mosquito. Plaquenil What You Need to Know - Kaleidoscope Fighting Lupus. A case of thrombocytopenia associated with the. Hydroxychloroquine - Wikipedia. Discussion Hydroxychloroquine has relative safety profile with 0.73% incidence of neutropenia. Though there are some case reports of its use to treat neutropenia in some condition like Felty's syndrome1, this is the first reported case of profound neutropenia to the best of our knowledge. Moved Permanently. The document has moved here. This article is a review of different management strategies for the hematological manifestations of systemic lupus erythematosus SLE, the strategies include immunosuppressive drugs, some noval therapies and B-cell depletion for refractory thrombocytopenia in patients with SLE and in antiphospholipid antibody syndrome associated with SLE.